Middle East and Africa Drug Delivery Market – Industry Trends and Forecast to 2027

  • Pharmaceutical
  • Published Report
  • Mar 2020
  • MEA
  • 350 Pages
  • No of Tables: 120
  • No of Figures: 30

Middle East and Africa Drug Delivery Market, By Product Type (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Opthalmic Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, Transmucosal Drug Delivery), End User (Hospitals, Community Healthcare, Home Healthcare, Clinics, Others), Distribution Channel (Hospital Pharmacies, Pharmacy Stores, Direct Tenders, Online Pharmacy), Country (South Africa and Rest of Middle East and Africa), Market Trends and Forecast to 2027

Middle East and Africa Drug Delivery Market

Market Analysis and Insights: Middle East and Africa Drug Delivery Market

Drug delivery market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.3% in the forecast period of 2020 to 2027 and is expected to reach USD 36.37 billion by 2027. Rising acceptance of self-administering drugs and increasing awareness about diagnosis and treatment around the globe is a driving factor for the market growth.

The process of introducing a therapeutic effect in the body of human by administering a drug at a specific targeted site is known as drug delivery. By controlling the rate, time and release of drug in the body, the safety and efficacy of drug can be improved. There can be many ways of delivering drugs like, oral, injectable, pulmonary, nasal and others. The drug delivery systems are made advanced by studying and exploiting the properties of nanoparticles, which have made the process of drug delivery more efficient and time saving.

Drug delivery market has increased with rising acceptance of self-administering drugs and increasing awareness about diagnosis and treatment in the developed as well as developing countries. For instance, by 2018 out of top one hundred drugs the sales from biological medicines is projected to account for 49% and also spending on biologics in the United States was seen to be USD 120.10 billion in 2017, which is a 12.5% increase over 2016.

Rising prevalence of chronic and non-chronic disease has increased the market for drug delivery devices as the numbers of people that are being treated are more and also the latest technological development has led to the treatment of very rare and impossible to treat diseases, therefore more people will be attracted towards them. Currently, rising demand for biosimilars and generic drugs has created an opportunities in the drug delivery market. However, risk of needle-stick injuries and side effects related to them like bacterial infection is estimated to restraint the market growth as people are getting more aware of the occupational diseases and the side effects of them hence it is a difficulty for drug delivery devices manufacturers and researchers.

This Drug Delivery Market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Middle East and Africa Drug Delivery Market

Middle East and Africa Drug Delivery Market Scope and Market Size

Drug delivery market is segmented on the basis of product type, end user, and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product type, the market is segmented into oral drug delivery, pulmonary drug delivery, injectable drug delivery, opthalmic drug delivery, nasal drug delivery, topical drug delivery, implantable drug delivery and transmucosal drug delivery. In 2020, oral drug delivery segment is expected to dominate the market due to the high reception of oral drug delivery route of administration by the patients as it is one of the humblest, convenient, and harmless routes for drug administration.
  • On the basis of end user, the market is segmented into hospitals, community healthcare, home healthcare, clinics and others. In 2020, hospitals segment is expected to dominate the market as hospitals are the first contact points for various types of treatments and surgical procedures, also the needs of all the in-house patients are catered.
  • On the basis of distribution channel, the market is segmented into hospital pharmacies, pharmacy stores, direct tenders and online pharmacy. In 2020, direct tenders segment is expected to dominate the market as cost benefits are provided to end users by direct tenders as compared to retail sales as well as direct tenders right away supply drug delivery devices from manufacturer to hospitals, dermatological clinics and others.

Drug Delivery Market Country Level Analysis

Drug delivery market is analysed and market size information is provided by country, product type, end user, and distribution channel as referenced above.

The countries covered in drug delivery market report are South Africa and Rest of Middle East & Africa. South Africa is leading in the Middle East and Africa as there is an increasing awareness about the diagnosis and treatment amongst the people.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Rising Demand of Fractional Drug Delivery

Drug delivery market report also provides you with detailed market analysis for every country growth in industry with sales, components sales, impact of technological development in Drug delivery and changes in regulatory scenarios with their support for the Drug delivery market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Drug Delivery Market Share Analysis

Drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Middle East and Africa drug delivery market.

The major players covered in the report are Johnson & Johnson Services, Inc., Novartis AG, F. Hoffmann-la Roche Ltd, Bayer AG, Pfizer Inc., 3M, GlaxoSmithKline Plc, Merck sharp & Dohme corp. (a subsidiary of Merck & co., Inc.), Nemera and Sanofi among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product developments are also initiated by the companies worldwide which are also accelerating the growth of drug delivery market.

For instance,

  • In January 2020, Bayer AG completed the submission of application for the U.S. approval of nifurtimox, which is a drug to treat pediatric patients with Chagas disease. This will mend the condition of children that are having this disease and also it will profit the company as it is a novel formulation for children and revenue generation will be increased for the organization.
  • In December 2019, F. Hoffmann-La Roche Ltd accomplished the acquisition of Spark Therapeutics, Inc. Spark is an organization which is dedicated to investigational gene therapy. This will open new opportunities for Roche and also will lead to more revenues.

Partnership, joint ventures and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for drug delivery through expanded range of size.

Customization Available : Middle East and Africa Drug Delivery Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 LIST OF FDA APPROVED BIOLOGICS, IN 2016

TABLE 2 MOST EXPENSIVE DRUGS IN THE U.S. 

TABLE 3 MAJOR PRODUCT RECALLS IN THE DRUG DELIVERY MARKET, 2019-2020

TABLE 4 LIST OF FDA APPROVED GENERICS, IN 2019

TABLE 5 PATENT EXPIRY OF DRUGS, 2019

TABLE 6 MIDDLE EAST AND AFRICA DRUG DELIVERY MARKET, BY PRODUCT TYPE , 2018-2027 (USD BILLION)

TABLE 7 MIDDLE EAST AND AFRICA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 8 MIDDLE EAST AND AFRICA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 9 MIDDLE EAST AND AFRICA SOLID ORAL DRUG IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 10 MIDDLE EAST AND AFRICA LIQUID ORAL DRUG IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 11 MIDDLE EAST AND AFRICA SEMI SOLID ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 12 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 13 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 14 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 15 MIDDLE EAST AND AFRICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 16 MIDDLE EAST AND AFRICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 17 MIDDLE EAST AND AFRICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 18 MIDDLE EAST AND AFRICA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 19 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 20 MIDDLE EAST AND AFRICA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 21 MIDDLE EAST AND AFRICA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 22 MIDDLE EAST AND AFRICA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 23 MIDDLE EAST AND AFRICA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 24 MIDDLE EAST AND AFRICA SEMI SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 25 MIDDLE EAST AND AFRICA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 26 MIDDLE EAST AND AFRICA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 27 MIDDLE EAST AND AFRICA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 28 MIDDLE EAST AND AFRICA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 29 MIDDLE EAST AND AFRICA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 30 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 31 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 32 MIDDLE EAST AND AFRICA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 33 MIDDLE EAST AND AFRICA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 34 MIDDLE EAST AND AFRICA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 35 MIDDLE EAST AND AFRICA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 36 MIDDLE EAST AND AFRICA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 37 MIDDLE EAST AND AFRICA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 38 MIDDLE EAST AND AFRICA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 39 MIDDLE EAST AND AFRICA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 40 MIDDLE EAST AND AFRICA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 41 MIDDLE EAST AND AFRICA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 42 MIDDLE EAST AND AFRICA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 43 MIDDLE EAST AND AFRICA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 44 MIDDLE EAST AND AFRICA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 45 MIDDLE EAST AND AFRICA HOPITALS IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 46 MIDDLE EAST AND AFRICA HOME HEALTHCARE IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 47 MIDDLE EAST AND AFRICA CLINICS IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 48 MIDDLE EAST AND AFRICA COMMUNITY HEALTHCARE IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 49 MIDDLE EAST AND AFRICA OTHERS IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 50 MIDDLE EAST AND AFRICA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 51 MIDDLE EAST AND AFRICA DIRECT TENDERS IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 52 MIDDLE EAST AND AFRICA HOSPITAL PHARMACIES IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 53 MIDDLE EAST AND AFRICA PHARMACY STORES IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 54 MIDDLE EAST AND AFRICA ONLINE PHARMACY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 55 MIDDLE EAST AND AFRICA DRUG DELIVERY MARKET, BY COUNTRY, 2018-2027 (USD BILLION)

TABLE 56 MIDDLE EAST AND AFRICA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 57 MIDDLE EAST AND AFRICA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 58 MIDDLE EAST AND AFRICA SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 59 MIDDLE EAST AND AFRICA LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 60 MIDDLE EAST AND AFRICA SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 61 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 62 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 63 MIDDLE EAST AND AFRICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 64 MIDDLE EAST AND AFRICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 65 MIDDLE EAST AND AFRICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 66 MIDDLE EAST AND AFRICA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 67 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 68 MIDDLE EAST AND AFRICA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 69 MIDDLE EAST AND AFRICA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 70 MIDDLE EAST AND AFRICA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 71 MIDDLE EAST AND AFRICA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 72 MIDDLE EAST AND AFRICA SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 73 MIDDLE EAST AND AFRICA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 74 MIDDLE EAST AND AFRICA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 75 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 76 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 77 MIDDLE EAST AND AFRICA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 78 MIDDLE EAST AND AFRICA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 79 MIDDLE EAST AND AFRICA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 80 MIDDLE EAST AND AFRICA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 81 MIDDLE EAST AND AFRICA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 82 MIDDLE EAST AND AFRICA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 83 MIDDLE EAST AND AFRICA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 84 MIDDLE EAST AND AFRICA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 85 MIDDLE EAST AND AFRICA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 86 MIDDLE EAST AND AFRICA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 87 MIDDLE EAST AND AFRICA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 88 SOUTH AFRICA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 89 SOUTH AFRICA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 90 SOUTH AFRICA SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 91 SOUTH AFRICA LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 92 SOUTH AFRICA SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 93 SOUTH AFRICA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 94 SOUTH AFRICA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 95 SOUTH AFRICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 96 SOUTH AFRICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 97 SOUTH AFRICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 98 SOUTH AFRICA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 99 SOUTH AFRICA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 100 SOUTH AFRICA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 101 SOUTH AFRICA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 102 SOUTH AFRICA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 103 SOUTH AFRICA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 104 SOUTH AFRICA SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 105 SOUTH AFRICA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 106 SOUTH AFRICA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 107 SOUTH AFRICA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 108 SOUTH AFRICA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 109 SOUTH AFRICA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 110 SOUTH AFRICA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 111 SOUTH AFRICA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 112 SOUTH AFRICA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 113 SOUTH AFRICA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 114 SOUTH AFRICA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 115 SOUTH AFRICA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 116 SOUTH AFRICA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 117 SOUTH AFRICA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 118 SOUTH AFRICA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 119 SOUTH AFRICA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 120 REST OF MIDDLE EAST AND AFRICA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

Browse Related Reports

Global Injectable Drug Delivery Market - Industry Trends and Forecast to 2025

North America Injectable Drug Delivery Market – Industry Trends and Forecast to 2027

Europe Injectable Drug Delivery Market – Industry Trends and Forecast to 2027

Asia-Pacific Injectable Drug Delivery Market – Industry Trends and Forecast to 2027

Europe Drug Delivery Market – Industry Trends and Forecast to 2027

Global Topical Drug Delivery Market – Industry Trends - Forecast to 2026

North America Drug Delivery Market – Industry Trends and Forecast to 2027

Europe Topical Drug Delivery Market – Industry Trends and Forecast to 2027

North America Topical Drug Delivery Market – Industry Trends and Forecast to 2027

Asia-Pacific Drug Delivery Market – Trends and Forecast to 2027

Global Implantable Drug Delivery Market – Industry Trends and Forecast to 2027

Global Pulmonary Drug Delivery Market - Industry Trends and Forecast to 2027

Global Oral Drug Delivery Market – Industry Trends and Forecast to 2027

Global Pulmonary/Respiratory Drug Delivery Market – Industry Trends and Forecast to 2027

Global Nasal Drug Delivery Market – Industry Trends and Forecast to 2027

Global Needle-Free Drug Delivery Market – Industry Trends - Forecast to 2026

Global Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

Asia-Pacific Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

Europe Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

Middle East - Africa Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

North America Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

Global Inflammatory Disease Drug Delivery Market – Industry Trends & Forecast to 2026

Global Buccal Drug Delivery Market - Industry Trends and Forecast to 2026

U.S. Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2027

Global Drug Delivery Market – Industry Trends and Forecast to 2027

Asia-Pacific Drug Delivery Market – Industry Trends and Forecast to 2027

Global Liposome Drug Delivery Market - Industry Trends and Forecast to 2027


Browse Related Blogs

Global Injectable drug delivery market is poised to reach USD 797.2 billion by 2022

Global Topical Drug Delivery Market is Expected to Reach an Estimated Value of USD 240.76 billion by 2026

North America Drug Delivery Market is poised to grow at 6.4% till 2024

Europe Drug Delivery Market is poised to grow at 7.3% from 2017 to 2024

Topical Drug Delivery Market to Grow at a CAGR of 9% in the Forecast Period of 2019 to 2026

Injectable Drug Delivery Market Rising at 12.4% CAGR Due to Surging Prevalence of Chronic Diseases

North America Injectable Drug Delivery Market is Poised to Grow at 11.0% to 2024

Asia-Pacific (APAC) Injectable Drug Delivery Market is Poised to Grow at 12.4% To 2024

Europe Injectable Drug Delivery Market Poised to Grow At 11.9% till 2024

Global Injectable Drug Delivery Market is Expected to Grow by CAGR 11.5% In The Forecast Period 2017 To 2024

North America Drug Delivery Market is Growing at a Significant Rate in the Forecast Period 2017-2024

North America Injectable Drug Delivery Market is Growing at a Significant Rate in the Forecast Period 2017-2024

Global Injectable Drug Delivery Market is Growing at a Significant Rate in the Forecast Period 2018-2025

Global Injectable Drug Delivery Market is Growing at a Significant Rate in the Forecast Period 2018-2025

Nasal Drug Delivery Market to Witness High Demand Due to Rising Respiratory Problems

Increasing Prevalence of Skin Disease or Condition, Rising Aging Population, Growth in Topical Drug Delivery, Increasing Research and Development of New Dermatological Drugs are Expected to Drive the Global Rx Dermatology Topical Drug Delivery Market in the forecast period of 2019-2026

Oral Drug Delivery Market 2019: Size, Share, Scope, Growth Opportunities Analysis By AbbVie, Inc., Amgen, Inc., Catalent Inc, Kemwell Bipharma., Pfizer, Inc., Novartis AG, Biocon, Sanofi, Novo Nordisk A/S. Johnson & Johnson Services, Inc. And Others

U.S. Rx Dermatology Topical Drug Delivery Market is Expected to grow at 4.9% in the Forecast Period of 2020 to 2027

Global Drug Delivery Market is Expected to grow at 8.0% in the Forecast Period of 2020 to 2027

Global Implantable Drug Delivery Market is Rising Exponentially at a CAGR of 8.0% in the Forecast Period

Global Pulmonary/Respiratory Drug Delivery Market is Rising Exponentially at a CAGR of 7.80%

Global Pulmonary Drug Delivery Market is Rising at a CAGR of 7.0% During the Anticipated Period of 2017 to 2024